NCT03487224 (LOSS) is a clinical trial of MRI with fMRI frequency in Hoarding Disorder, sponsored by Stanford University.

Who is sponsoring NCT03487224?

NCT03487224 is sponsored by Stanford University.

What drugs are being tested in NCT03487224?

Interventions in NCT03487224: MRI with fMRI frequency.

What condition does NCT03487224 study?

NCT03487224 studies Hoarding Disorder.

Is NCT03487224 still recruiting?

NCT03487224 is currently active, enrolled. Last updated 16 July 2025.

Last reviewed 2025-07-16 · How we verify

NCT03487224: LOSS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neural Mechanisms of Decision Making in Hoarding Disorder

Active, enrolled Last updated 16 July 2025

What this trial tests

trial testing MRI with fMRI frequency in Hoarding Disorder in 25 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

8 July 2018

Primary endpoint
30 May 2026

30 May 2026

Quick facts

Lead sponsor	Stanford University
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	25
Start date	8 July 2018
Primary completion	30 May 2026
Estimated completion	30 May 2026
Sites	1 location across United States

Drugs / interventions tested

MRI with fMRI frequency

Conditions studied

Hoarding Disorder — all drugs for Hoarding Disorder →

Sponsor

Stanford University

Who can join

Adults 18 to 70, any sex, with Hoarding Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hoarding Disorder

Currently open trials in the same condition.

NCT06712914 — Rapid Non-Invasive Brain Stimulation for Hoarding Disorder · NA · recruiting
NCT07483021 — Detection of Hoarding Disorder and Related Psychopathology · NA · recruiting
NCT04712474 — In-home Decluttering Augmentation of Group CBT for HD · NA · active not recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03487224 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 16 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03487224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing